References
- Szefler S J, Apter A. Advances in pediatric and adult asthma. J Allergy Clin Immunol 2005; 115: 470–477
- Finkelman F D, Vercelli D. Advances in asthma, allergy mechanisms, and genetics in 2006. J Allergy Clin Immunol 2007; 120: 544–550
- Barnes P J. Novel signal transduction modulators for the treatment of airway diseases. Pharmacol Ther 2006; 109: 238–245
- Amon A, Pahl A, Szelenyi I. Are there any realistic chances to develop new drugs for asthma?. Drug News Perspect 2006; 19: 189–200
- Roquet A, Dahlén B, Kumlin M, Ihre E, Anstrén G, Binks S, Dahlén S E. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997; 155: 1856–1863
- Hallstrand T S, Moody M W, Wurfel M M, Schwartz L B, Henderson W R, Jr, Aitken M L. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2005; 172: 679–686
- Anderson S D. How does exercise cause asthma attacks?. Curr Opin Allergy Clin Immunol 2006; 6: 37–42
- Dirksen A, Engel T, Frølund L, Heinig J H, Svendsen U G, Weeke B. Effect of a non-sedative antihistaminic (loratadine) in moderate asthma. A double-blind controlled clinical crossover-trial. Allergy 1989; 44: 566–571
- Reicin A, White R, Weinstein S F, Finn A F, Jr, Nguyen H, Peszek I, et al. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 2000; 160: 2481–2488
- Reiss T F, Knorr B, Malmstrom K, Noonan G, Lu S. Clinical efficacy of montelukast in adults and children. Clin Exp Allergy Rev 2001; 1: 264–273
- Bjermer L. Montelukast in the treatment of asthma as a systemic disease. Expert Rev Clin Immonol 2005; 1: 325–336
- Wilson A M. Are antihistamines useful in managing asthma?. Curr Opin Allergy Clin Immunol 2002; 2: 53–59
- Nelson H S. Prospects for antihistamines in the treatment of asthma. J Allergy Clin Immunol 2003; 112: S96–100
- Santanello N C, Barber B L, Reiss T F, Friedman B S, Juniper E F, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997; 10: 646–651
- Juniper E F, Guyatt G H, Epstein R S, Ferrie P J, Jaeschke R, Hiller T K. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76–83
- Nathan R A, Finn A F, Jr, LaForce C, Ratner P, Chapman D, de Guia E C, Hewlett D, Kramer B. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study. Ann Allergy Asthma Immunol 2006; 97: 389–396
- Pasquali M, Baiardini I, Rogkakou A, Riccio A M, Gamalero C, Descalzi D, Folli C, Passalacqua G, Canonica G W. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 2006; 36: 1161–1164
- Grant J A, Nicodemus C F, Findlay S R, Glovsky M M, Grossman J, Kaiser H, Meltzer E O, Mitchell D Q, Pearlman D, Selner J, Geissler L, Seidenberg B C. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995; 95: 923–932
- Davis B E, Todd D C, Cockcroft D W. Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. J Allergy Clin Immunol 2005; 116: 768–772
- National Asthma Education and Prevention Program (NAEPP) Coordinating Committee. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma, http://www.nhlbi.nih.gov/guidelines/archives/epr-2/asthgdln_archive.pdf Accessed January 27, 2009
- National Asthma Education and Prevention Program (NAEPP) Coordinating Committee. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.htm Accessed January 27, 2009